
Weight management • appetite control • metabolic health
Tirzepatide 20 mg
Prefilled pen
20 mg/3 ml · doses 1–5 mg
A dual GIP and GLP-1 receptor agonist that helps regulate appetite, blood glucose and energy balance.
- Reduced appetite
- Increased feelings of fullness
- Improved blood-glucose control
- Significant body-weight reduction in clinical studies
Mounjaro® is the registered brand name for tirzepatide owned by Eli Lilly and Company. VLS Peptides is not affiliated with or endorsed by Eli Lilly. This product is not Mounjaro® and should only be used under appropriate medical supervision.







